{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:11:30Z","timestamp":1776395490392,"version":"3.51.2"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.urology.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T18:12:59Z","timestamp":1455905579000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Contemporary Review of Treatment Options for Peyronie's Disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Benjamin A.","family":"Sherer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.02.009_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.ijir.3900863","article-title":"Epidemiology of Peyronie's disease","volume":"14","author":"Sommer","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0015","doi-asserted-by":"crossref","first-page":"282503","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"DiBenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0020","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1743-6109.2007.00537.x","article-title":"A survey of primary-care physicians and urologists regarding Peyronie's disease","volume":"2","author":"LaRochelle","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-5347(01)65359-X","article-title":"The anatomy of the tunica albuginea in the normal penis and Peyronie's disease","volume":"157","author":"Brock","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00024382-199510000-00001","article-title":"Wound healing: the role of the macrophage and other immune cells","volume":"4","author":"DiPietro","year":"1995","journal-title":"Shock"},{"key":"10.1016\/j.urology.2016.02.009_bib0035","first-page":"391","article-title":"Matrix metalloproteinases in wound repair","volume":"6","author":"Ravanti","year":"2000","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0040","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1743-6109.2008.01011.x","article-title":"Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie's disease?","volume":"5","author":"Gelbard","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.urology.2016.02.009_bib0050","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.juro.2008.01.093","article-title":"Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1\u03b2 and transforming growth factor-\u03b2 in Peyronie's plaque fibroblasts","volume":"179","author":"Del Carlo","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0060","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The medical management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2164\/jandrol.110.011031","article-title":"Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients","volume":"32","author":"Kadioglu","year":"2011","journal-title":"J Androl"},{"key":"10.1016\/j.urology.2016.02.009_bib0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1517\/14656566.2015.1041503","article-title":"Pharmacologic therapy for Peyronie's disease: what should we prescribe?","volume":"16","author":"Sherer","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urology.2016.02.009_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","article-title":"L-arginine and phosphodiesterase inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures","volume":"9","author":"Valente","year":"2003","journal-title":"Nitric Oxid"},{"key":"10.1016\/j.urology.2016.02.009_bib0080","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-5347(17)66108-1","article-title":"Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba)","volume":"81","author":"Zarafonetis","year":"1959","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease; a prospective, placebo-controlled, randomized study","volume":"47","author":"Weidner","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/187152812798889321","article-title":"Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic \u201crationale\u201d and related emerging treatment strategies","volume":"11","author":"Paulis","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.urology.2016.02.009_bib0095","first-page":"41","article-title":"Controlled clinical trial of vitamin E in Peyronie's disease","volume":"9","author":"Pryor","year":"1983","journal-title":"Program Reprod Biol Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0100","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1992.tb15836.x","article-title":"The treatment of Peyronie's disease with tamoxifen","volume":"70","author":"Ralph","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0110","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","article-title":"Tamoxifen versus placebo in the treatment of Peyronie's disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1464-410X.1978.tb03038.x","article-title":"Procarbazine (Natulan) in the treatment of Peyronie's disease","volume":"50","author":"Morgan","year":"1978","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1083\/jcb.25.1.145","article-title":"The mechanism of colchicine inhibition of mitosis. I. Kinetics of inhibition and the binding of H3 colchicine","volume":"25","author":"Taylor","year":"1965","journal-title":"J Cell Biol"},{"key":"10.1016\/j.urology.2016.02.009_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","article-title":"Is colchicine effective in Peyronie's disease? A pilot study","volume":"44","author":"Akkus","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","article-title":"Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study","volume":"16","author":"Safarinejad","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0135","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine\u2014metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1016\/j.urology.2016.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","article-title":"Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study","volume":"178","author":"Safarinejad","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","article-title":"A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease","volume":"106","author":"Safarinejad","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0150","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1743-6109.2009.01235.x","article-title":"Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: a prospective, randomized, double-blind placebo-controlled study","volume":"6","author":"Safarinejad","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ijir.2010.20","article-title":"Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study","volume":"22","author":"Safarinejad","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0160","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11845-013-1036-5","article-title":"Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction","volume":"183","author":"Ozturk","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.urology.2016.02.009_bib0165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-5347(17)52339-3","article-title":"Topical beta-aminopropionitrile in the treatment of Peyronie's disease","volume":"129","author":"Gelbard","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2005.04.011","article-title":"Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study","volume":"48","author":"Riedl","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1743-6109.2006.00417.x","article-title":"Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease\u2014a placebo-controlled pilot study","volume":"4","author":"Fitch","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0180","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/S0022-5347(05)64173-0","article-title":"Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea","volume":"168","author":"Martin","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0185","article-title":"Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study","author":"Twidwell","year":"2015","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0190","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/01.ju.0000056153.47716.d0","article-title":"Tunica albuginea tissue analysis after electromotive drug administration","volume":"169","author":"Levine","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0195","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ju.0000116450.82816.2c","article-title":"A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease","volume":"171","author":"Di Stasi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0200","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","article-title":"Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial","volume":"177","author":"Greenfield","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2011.45","article-title":"Review of non-surgical treatment options for Peyronie's disease","volume":"24","author":"Larsen","year":"2012","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0210","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie's disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0215","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.02.009_bib0230","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2007.01.080","article-title":"Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease","volume":"69","author":"Cavallini","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0235","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","article-title":"Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0245","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2013.05.022","article-title":"Outcomes of intralesional interferon-\u03b12B for the treatment of Peyronie disease","volume":"190","author":"Trost","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0250","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/jsm.12312","article-title":"Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"10","author":"Gelbard","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0255","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1074\/jbc.M003450200","article-title":"Substrate recognition by the collagen-binding domain of Clostridium histolyticum class I collagenase","volume":"276","author":"Matsushita","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2016.02.009_bib0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/ijr.11.4","article-title":"Collagenase clostridium histolyticum: a novel nonoperative treatment for Dupuytren's disease","volume":"6","author":"Watt","year":"2011","journal-title":"Int J Clin Rhematol"},{"key":"10.1016\/j.urology.2016.02.009_bib0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0270","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase clostridium histolyticum in the treatment of Peyronie's disease by subgroups: results from two large, double-blind, randomized, placebo-controlled, phase 3 studies","volume":"116","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0275","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s11255-015-1074-1","article-title":"Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease","volume":"47","author":"Romano","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.02.009_bib0280","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2012.10.049","article-title":"Adipose-derived stem cells for the treatment of Peyronie's disease?","volume":"63","author":"Lin","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","article-title":"Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease","volume":"63","author":"Castiglione","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0290","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.7556\/jaoa.2015.124","article-title":"Effects of stem cell treatment in human patients with Peyronie disease","volume":"115","author":"Levy","year":"2015","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.urology.2016.02.009_bib0295","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and ED: results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.urology.2016.02.009_bib0300","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jsm.12275","article-title":"Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study","volume":"10","author":"Hatzichristodoulou","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0305","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0360-3016(00)00505-8","article-title":"Low-dose radiotherapy in 179 patients with Peyronie's disease: treatment outcome and current sexual functioning","volume":"47","author":"Incrocci","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2016.02.009_bib0310","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1743-6109.2012.02677.x","article-title":"Radiation therapy in Peyronie's disease","volume":"9","author":"Mulhall","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/ten.teb.2008.0020","article-title":"Implications of tensile loading for the tissue engineering of nerves","volume":"14","author":"Bueno","year":"2008","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.urology.2016.02.009_bib0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.22203\/eCM.v015a05","article-title":"Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts","volume":"15","author":"Shapiro","year":"2008","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.urology.2016.02.009_bib0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2008.05.002","article-title":"Growth control by intracellular tension and extracellular stiffness","volume":"18","author":"Assoian","year":"2008","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.urology.2016.02.009_bib0330","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","article-title":"Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study","volume":"5","author":"Levine","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0335","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jsm.12400","article-title":"Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation","volume":"11","author":"Martinez-Salamanca","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0340","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","article-title":"Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study","volume":"6","author":"Gontero","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0345","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","article-title":"Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease","volume":"9","author":"Abern","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0350","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease","volume":"106","author":"Raheem","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0090-4295(97)00706-1","article-title":"Unusual complications of the vacuum erection device","volume":"51","author":"Ganem","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0360","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1871528111312010009","article-title":"Peironimev-Plus\u00ae in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). Results of a controlled study","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.urology.2016.02.009_bib0365","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0022-5347(01)68184-9","article-title":"A surgical algorithm for the treatment of Peyronie's disease","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)39871-3","article-title":"Modified corporoplasty for the treatment of penile curvature","volume":"143","author":"Yachia","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0375","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0090-4295(85)90285-7","article-title":"New surgical treatment for Peyronie disease","volume":"25","author":"Essed","year":"1985","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0380","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1464-410X.1987.tb05497.x","article-title":"Congenital penile angulation","volume":"60","author":"Ebbehoj","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0385","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/S0022-5347(05)65085-9","article-title":"Correction of penile curvature using the 16-dot plication technique: a review of 132 patients","volume":"167","author":"Gholami","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1743-6109.2007.00429.x","article-title":"16-dot procedure for penile curvature","volume":"2","author":"Brandt","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0395","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0022-5347(17)35341-7","article-title":"Dorsal tunica albuginea plication for hypospadias curvature","volume":"151","author":"Baskin","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0400","series-title":"Peyronie's Disease: A Guide to Clinical Management","first-page":"151","article-title":"Penile straightening with tunica albuginea plication: TAP procedure","author":"Levine","year":"2006"},{"key":"10.1016\/j.urology.2016.02.009_bib0405","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(05)00063-7","article-title":"Factors affecting the loss of length associated with tunica albuginea plication for correction of curvature","volume":"175","author":"Greenfield","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0410","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrurol.2010.233","article-title":"Current status of the surgical management of Peyronie's disease","volume":"8","author":"Kadioglu","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0415","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1464-410X.2004.05031.x","article-title":"Surgical alternatives for treating Peyronie's disease","volume":"94","author":"Tornehl","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042307-200411000-00015","article-title":"Critical analysis of surgery for Peyronie's disease","volume":"14","author":"Kendirci","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0425","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1743-6109.2011.02460.x","article-title":"Predicting ED following surgical correction of Peyronie's disease without inflatable penile prosthesis placement: vascular assessment and preoperative risk factors","volume":"9","author":"Taylor","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0430","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1743-6109.2011.02299.x","article-title":"ED after plaque incision and grafting: short-term assessment of incidence and predictors","volume":"8","author":"Flores","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0435","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-5347(05)67639-2","article-title":"Application of pericardial graft in the surgical management of Peyronie's disease","volume":"163","author":"Hellstrom","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0440","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1464-410X.2005.05459.x","article-title":"The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease","volume":"95","author":"Kalsi","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0445","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.juro.2007.08.044","article-title":"Use of small intestinal submucosa graft for the surgical management of Peyronie's disease","volume":"178","author":"Knoll","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0450","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1743-6109.2010.02102.x","article-title":"Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction","volume":"8","author":"Chung","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0455","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.ijir.3900676","article-title":"Long-term follow-up on use of pericardial graft in the surgical management of Peyronie's disease","volume":"13","author":"Leungwattanakij","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0460","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1743-6109.2008.00941.x","article-title":"Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up","volume":"5","author":"Taylor","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0465","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/aja.2011.117","article-title":"Long-term results of the surgical treatment of Peyronie's disease with plaque incision and grafting","volume":"13","author":"Ralph","year":"2011","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urology.2016.02.009_bib0470","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0022-5347(01)66891-5","article-title":"Relaxing incisions in the correction of penile deformity due to Peyronie's disease","volume":"154","author":"Gelbard","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0475","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1464-410X.2004.05220.x","article-title":"A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles","volume":"94","author":"Egydio","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0480","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/jsm.12462","article-title":"A geometric model of plaque incision and graft of Peyronie's disease with geometric analysis of different techniques","volume":"11","author":"Miranda","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0485","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1743-6109.2011.02370.x","article-title":"Partial plaque excision and grafting (PEG) for Peyronie's disease","volume":"8","author":"Levine","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0490","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.urology.2015.04.027","article-title":"Bone saw for calcified Peyronie's disease plaques","volume":"86","author":"Ostrowski","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0495","first-page":"E213","article-title":"Penile length and girth restoration in severe Peyronie's disease using circular and longitudinal grafting","volume":"11","author":"Egydio","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.02.009_bib0500","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-5347(17)68843-8","article-title":"Further experiences with an operation for the cure of Peyronie's disease","volume":"63","author":"Lowsley","year":"1950","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0505","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-5347(17)59886-9","article-title":"The surgical treatment of Peyronie's disease with a dermal graft","volume":"111","author":"Devine","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0510","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-5347(17)55682-7","article-title":"Peyronie's disease: excision and autografting with tunica vaginalis","volume":"124","author":"Das","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0515","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0302-2838(02)00071-4","article-title":"Peyronie's disease. Surgical correction of 40 patients with relaxing incision and duramater graft","volume":"41","author":"Sampaio","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0520","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0022-5347(01)62239-0","article-title":"Venous patch graft for Peyronie's disease. Part I: technique","volume":"160","author":"Lue","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0525","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-5347(05)67459-9","article-title":"Penile straightening with crural graft of the corpus cavernosum","volume":"164","author":"Teloken","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0530","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eururo.2005.01.018","article-title":"The surgical treatment of Peyronie's disease: replacement of plaque by free autograft of buccal mucosa","volume":"48","author":"Shioshvili","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0535","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0090-4295(00)01079-7","article-title":"Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease","volume":"57","author":"Knoll","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.009_bib0540","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.juro.2006.09.051","article-title":"Complications of porcine small intestine submucosa graft for Peyronie's disease","volume":"177","author":"Breyer","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0545","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1743-6109.2005.20234.x","article-title":"Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative ED","volume":"2","author":"Levine","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0550","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","article-title":"A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions","volume":"9","author":"Rybak","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0555","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1111\/j.1743-6109.2010.01971.x","article-title":"Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant ED: a single-center study","volume":"7","author":"Levine","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0560","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","article-title":"A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis","volume":"152","author":"Wilson","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0565","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-5347(05)66537-8","article-title":"Long-term follow-up of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis","volume":"165","author":"Wilson","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0570","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/jsm.12009","article-title":"Comparison between AMS 700\u2122 CX and Coloplast\u2122 Titan Inflatable Penile Prosthesis for Peyronie's disease treatment and remodeling: clinical outcomes and patient satisfaction","volume":"11","author":"Chung","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0575","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ijir.3900515","article-title":"A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie's disease","volume":"12","author":"Dimitriou","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2016.02.009_bib0580","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.eururo.2006.10.027","article-title":"Penile prosthesis implantation: size matters","volume":"51","author":"Montague","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.02.009_bib0585","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/aja.2009.35","article-title":"Prospective and long-term evaluation of erect penile length obtained with inflatable penile prosthesis to that induced by intracavernosal injection","volume":"11","author":"Wang","year":"2009","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urology.2016.02.009_bib0590","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1743-6109.2011.02285.x","article-title":"Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study","volume":"8","author":"Levine","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.02.009_bib0595","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1743-6109.2012.02675.x","article-title":"A new, innovative, lengthening surgical procedure for Peyronie's disease by penile prosthesis implantation with double dorsal-ventral patch graft: the \u201csliding technique\u201d","volume":"9","author":"Rolle","year":"2012","journal-title":"J Sex Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951600145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951600145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:47:19Z","timestamp":1567626439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951600145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":118,"alternative-id":["S009042951600145X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.02.009","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Review of Treatment Options for Peyronie's Disease","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}